HECA: A Protein in Cell Signaling and Disease (G51696)

Target Name: HECA

NCBI ID: G51696

HECA

HECA: A Protein in Cell Signaling and Disease

HECA (hHDC), also known as human epidermal growth factor receptor alpha, is a protein that is expressed in the skin and other tissues. It plays a role in cell signaling, specifically in the regulation of cell growth, differentiation, and survival. HECA has also been shown to be involved in a variety of diseases, including cancer, obesity, and diabetes. As a result, HECA has become a focus of interest in the development of new treatments.

One of the main functions of HECA is its role in cell signaling. HECA is a transmembrane protein that is involved in the formation of a complex between the cytoskeleton and the cytoplasm. This complex is known as the cytoskeleton- cytoplasmic interaction and is critical for the regulation of cell growth and differentiation.

HECA is also involved in the regulation of cell survival. In cancer cells, HECA has been shown to promote cell survival by inhibiting the ability of cells to undergo apoptosis, which is a natural mechanism for cell death. This increase in cell survival can contribute to the development and progression of cancer.

In addition to its role in cell signaling, HECA has also been shown to be involved in the regulation of obesity. Obesity is a condition that is characterized by an excess of body weight and can lead to a variety of health problems, including heart disease, diabetes, and certain cancers. HECA has been shown to play a role in the regulation of obesity by affecting the activity of genes that are involved in the production of fat.

HECA is also a potential biomarker for certain diseases. For example, HECA has been shown to be elevated in the blood of people with type 2 diabetes, a condition that is characterized by high blood sugar levels. This increase in HECA levels may indicate the presence of certain diseases, such as diabetes.

In conclusion, HECA is a protein that is involved in a variety of processes in the body. Its role in cell signaling, cell survival, and obesity make it a potential drug target. Further research is needed to fully understand the role of HECA in these processes and to develop new treatments for diseases associated with HECA.

Protein Name: Hdc Homolog, Cell Cycle Regulator

Functions: May play an important role in some human cancers. May be part of the regulatory mechanism in the development of epithelial tube networks such as the circulatory system and lungs

The "HECA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HECA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets